Linedata Nabs Risk Analytics, Portfolio Management Vendor Derivation

Linedata's asset management platform will see major upgrades as a result of the acquisition.

deal-hand-pen

Buy-side-focused solutions provider Linedata announced the acquisition of Derivation, which specializes in risk, analytics and portfolio management solutions for the buy side.

Derivation, which was founded in 1996 and is headquartered in England, employs less than 20 people and saw revenues of roughly £2 million ($2.82 million) in 2015. Linedata has nearly 1,000 employees in 16 offices. The firm achieved €172.3 million ($196.5 million) in revenues in 2015.

"Offering our clients global, high-quality, scalable solutions is a cornerstone of our Linedata 2018 global leadership strategy. Having a comprehensive range of asset management solutions is key to leading the sector and driving our growth", said Anvaraly Jiva, founder and CEO of Linedata, in a statement "The teams at Derivation share our values of customer service and entrepreneurship, and we are delighted to welcome them into Linedata."

After the acquisition, Linedata plans on releasing major updates to its asset management platform, specifically focusing on improving coverage of MiFID II, enhanced compliance monitoring and advanced fixed-income and derivative portfolio management.

There have been a slew of acquisitions on the buy side around risk platforms this year, as discussed in a recent episode of the Waters Wavelength podcast.

 

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: